Epistasis and the genetics of disease resistance (360G-Wellcome-096063_Z_11_Z)
I have shown that two epistatic interactions (a cancellation of malaria protection when alpha thalassaemia and sickle cell are coinherited, and an alleviation of blood disorder when alpha and beta thalassaeamia are coinherited) could explain aspects of the distribution of the malaria protective haemoglobinopathies: particularly the rarity of sickle cell in the Mediterranean region (Penman et al, 2010). The goals of the first part of this proposal are to (i) use mathematical models to determine w hether epistasis could account for the east/West divide between sickle cell and HbE; (ii) analyse a detailed population genetic dataset from Kenya to look for new epistatic interactions between malaria protective genes, and (iii) conduct in vitro studies to determine whether erythrocytes carrying both alpha and beta thalassaemia offer malaria protection. Two crucial sets of human immune system genes: the HLAs and the KIRs display striking genomic organisation. For the second part of this p roposal, my goal is to investigate whether epistatic interactions could help maintain HLA and KIR haplotypes. I will build mathematical models that capture the interplay between HLA loci, KIR loci and pathogen selection, and test the models predictions against HLA and KIR sequence data in online databases.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 250000 |
Applicant Surname | Penman |
Approval Committee | Sir Henry Wellcome Postdoctoral Fellowships Interview Committee |
Award Date | 2011-05-23T00:00:00+00:00 |
Financial Year | 2010/11 |
Grant Programme: Title | Sir Henry Wellcome Postdoctoral Fellowship |
Internal ID | 096063/Z/11/Z |
Lead Applicant | Dr Bridget Penman |
Partnership Value | 250000 |
Planned Dates: End Date | 2016-01-31T00:00:00+00:00 |
Planned Dates: Start Date | 2011-08-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | South East |
Sponsor(s) | Prof Paul Harvey |